Tesla posted record deliveries and a massive revenue beat, yet watched $71 billion in market cap vanish overnight. What analysts are telling clients now about the road ahead reveals a striking split between the…
Some Dividend Kings have quietly raised their payouts every single year for seven decades, yet most investors have never heard their names. Finding out which companies built that kind of streak reveals a lot…
The Fed has been cutting rates, yet long-term Treasury yields are climbing and bond ETFs are swinging wildly in response. Three funds cut through that contradiction in very different ways, and choosing the wrong…
Coinbase and SoFi both operate at the edge of fintech and crypto, but their Q1 2026 results tell two radically different stories about which kind of risk actually pays off for investors right now.
Fixed-rate bonds cannot outrun inflation over a 25-year retirement, yet most boomers keep reaching for them anyway. Three companies have raised their dividends for between 50 and 70 consecutive years and may offer a…
Citigroup just called the Magnificent Seven dead, and the charts of some members make it hard to argue. But one Wall Street analyst sees something hiding inside the carnage that most investors are completely…
XRP has shed 70% from its peak and shows several classic signs that sellers have exhausted themselves, but the coin still needs one specific catalyst before buyers will commit real money.
XBI and PBE both bet on biotech, but their structures pull in opposite directions when markets turn volatile. Knowing which one fits your risk appetite could mean the difference between riding a catalyst wave…
Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions sent every major index deep into the red. See which stocks analysts are upgrading, downgrading, and initiating fresh…
Institutional money is quietly rotating into the infrastructure layer beneath the GPU trade, and three under-the-radar names are already posting numbers that suggest Wall Street hasn't caught up to the story yet.
CVS Health stock has surged nearly 80% in a year while the quarterly dividend has sat frozen for ten straight quarters, raising a pointed question for income investors: is this pause a sign of…
Mark Cuban thinks AI's infrastructure frenzy is setting up investors for a painful reckoning, and one $100 billion mega-campus in Utah is already discovering what happens when ambition collides with state politics, a shrinking…
The federal government may lose hundreds of billions of dollars to fraud every year, but the one statistic Treasury Secretary Bessent keeps citing comes from a single contested document that the Biden White House…
Oracle just scored a blockbuster Pentagon contract while its stock sits near a decade low and Larry Ellison has watched more than $200 billion evaporate from his net worth. Whether this deal signals a…
A collapsed ceasefire, a choked oil strait, and a bond market on edge are pushing mortgage rates to levels most buyers hoped they'd never see again. Here is how a war thousands of miles…
